2017-11-06T11:03:21-06:00 2016-12-31 470900880 Calibre CPA Group PLLC 566 West Lake St Suite 300 Chicago IL 60661 990 2016-01-01 366009467 ORTHOPAEDIC RESEARCH & EDUCATION FOUNDATION ORTH 8476989980 9400 W HIGGINS RD SUITE 215 ROSEMONT IL 600184975 P JOANNE RAY CHEIF EXECUTIVE OFFICER 8476989980 2017-08-24 1 Joseph Pierson P00189462 3126550037 38.100.43.100 2017-11-06 11:03:09 CS P DD2F5A6855584BEFBC68452237D9336111CE352F DD2F5A6855584BEFBC68452237D9336111CE352F 2016 2017-02-10 21:41:12Z P JOANNE RAY 9400 W HIGGINS RD SUITE 215 ROSEMONT IL 600184975 17981727 0 X WWW.OREF.COM X 1955 IL IMPROVING LIVES BY SUPPORTING EXCELLENCE IN ORTHOPAEDIC RESEARCH. 22 22 15 200 0 0 5097325 4715824 0 0 719136 389409 0 0 5816461 5105233 2511642 1894516 0 0 1703341 1667205 0 0 1710204 1408481 1603987 5623464 5165708 192997 -60475 30480383 25717011 4530248 3944483 25950135 21772528 X THE ORTHOPAEDIC RESEARCH AND EDUCATION FOUNDATION (OREF) MISSION IS IMPROVING LIVES BY SUPPORTING EXCELLENCE IN ORTHOPAEDIC RESEARCH. THE FOUNDATION'S VISION IS THAT IT WILL BE THE LEADER IN SUPPORTING ORTHOPAEDIC RESEARCH TO IMPROVE FUNCTION, ELIMINATE PAIN AND RESTORE MOBILITY. 0 0 2445756 1874516 GRANT PROGRAM: THE PURPOSE OF THE FOUNDATION IS TO SUPPORT RSEARCH INTO THE CAUSES AND TREATMENT OF MUSCULOSKELETAL DISEASES AND INJURIES. OREF'S NICHE IS SUPPORTING SURGEON-RESEARCHERS AND PHD-RESEARCHERS IN BASIC SCIENCE/TRANSLATION, CLINICAL, AND HEALTH SERVICES RESEARCH. 26095 20000 FOR THE NEW MEDICAL RESEARCH IN ORTHOPAEDICS, OREF'S EDUCATION PROGRAM OFFERS THE OPPORTUNITY TO DEVELOP THEIR RESEARCH INTERESTS AND SKILLS. THROUGH EDUCATIONAL PROGRAMMING, OREF SUPPORTS EMERGING TALENT TO HELP THEM SUCCESSFULLY PURSUE RESEARCH CAREERS. 2471851 1 1 0 0 0 0 0 0 1 1 1 0 0 1 0 0 1 0 0 0 1 1 0 0 0 0 0 1 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 1 15 0 15 1 0 0 0 0 0 1 1 0 0 X 22 22 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 AK AL AR AZ CA CT DC DE FL GA IL IN KS KY LA MA MD ME MI MS MN MO MT NC ND NE NJ NH NM NY OH OK OR PA RI SC SD TN UT VA WA WI WV WY X X RHONDA DIRR 8476989980 9400 W HIGGINS RD SUITE 215 ROSEMONT IL 600184975 B Sonny Bal MD JD MBA TRUSTEE 5.00 X 0 0 0 Christopher Adams MD TRUSTEE 5.00 X 0 0 0 David C Dvorak JD TRUSTEE 5.00 X 0 0 0 James R Fricke MD TRUSTEE 5.00 X 0 0 0 Jeffrey S Adams TRUSTEE 5.00 X 0 0 0 John A Bergfeld MD TRUSTEE 5.00 X 0 0 0 John H Healey MD TRUSTEE 5.00 X 0 0 0 John R Tongue MD TRUSTEE 5.00 X 0 0 0 Joshua J Jacobs MD TRUSTEE 5.00 X 0 0 0 Lawrence G Lenke MD TRUSTEE 5.00 X 0 0 0 Letha Y Griffin MD PhD TRUSTEE 5.00 X 0 0 0 Matthew B Dobbs MD TRUSTEE 5.00 X 0 0 0 Michael L Parks MD President-Elect 5.00 X 0 0 0 Paul C Collins MD TRUSTEE 5.00 X 0 0 0 Thomas P Sculco MD TRUSTEE 5.00 X 0 0 0 William C McMaster MD TRUSTEE 5.00 X 0 0 0 David G Lewallen MD President 5.00 X 0 0 0 Farshid Guilak PhD Chair-Research Grants 5.00 X 0 0 0 James G Borovsky Secretary-Treasurer 5.00 X 0 0 0 John J Callaghan MD Past-President 5.00 X 0 0 0 Richard F Kyle MD Chair, Corporate Relations 5.00 X 0 0 0 Richard F Santore MD Chair, Individual Development 5.00 X 0 0 0 EDWARD HOOVER VP DEVELOPMENT 40.00 X 128767 0 12929 CAROL WARGO VP STRATEGIC PTRS 40.00 X 141934 0 16709 KAREN PUBENTZ DIRECTOR OF COMM 40.00 X 113946 0 17700 PONDA BARNES DIRECTOR OF GRANTS 40.00 X 112571 0 10067 SHARON MELLOR PHD CAE FORMER CHIEF EXEC 40.00 X 241153 0 36320 738371 0 93725 5 1 1 0 0 4715824 96921 4715824 431365 431365 12834538 12876494 -41956 -41956 -41956 5105233 0 0 389409 1824724 1824724 20000 20000 49792 49792 738371 126066 287023 325282 590549 104596 216068 269885 92870 16120 35158 41592 153828 24222 64175 65431 91587 15897 34672 41018 135077 14751 87663 32663 9703 3299 3202 3202 33955 11545 11205 11205 37227 18614 18613 48000 16320 15840 15840 183803 62958 1090 119755 91325 21941 37459 31925 80454 24341 25934 30179 127797 21930 49281 56586 70739 9583 29442 31714 228949 74556 31708 122685 34914 6060 13217 15637 31170 4536 22232 4402 BAD DEBT 377654 377654 LIFE INSURANCE PREMIUMS 79060 79060 RECOGNITION AWARDS 12006 1889 10117 DUES AND SUBSCRIPTIONS 8973 3214 5759 13181 13181 5165708 2471851 983653 1710204 4371099 3903657 2619731 2762331 81103 83718 322725 151329 154529 171396 18029590 13444047 5224331 5351862 30480383 25717011 265659 190179 2695804 2807986 1568785 946318 4530248 3944483 X -3927260 -2497081 6274946 7085820 23602449 17183789 25950135 21772528 30480383 25717011 -60475 952378 -5069510 X 0 1 X 1 0 X 5154975 6370076 4520407 5097325 4715824 25858607 5154975 6370076 4520407 5097325 4715824 25858607 25858607 720388 872830 904836 805283 431365 3734702 29593309 0.87380 0.74090 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 1 X 12835718 48562 953270 6230393 271935 7335222 22513401 62327 -2148068 7564692 27250 12835718 26167534 103477 535123 260879 4031854 22513401 25563123 1023628 2442972 2862189 26167534 20816303 2539740 2207080 25563123 1.00000 1 0 50447 8885 41562 272278 142444 129834 171396 CHARITABLE REMAINDER TRUST RECEIVABLE 3115280 CASH SURRENDER VALUE OF LIFE INSURANCE 2156437 OTHER RECEIVALBLES 80145 5351862 6120664 952378 63053 1015431 5105233 0 5105233 10298271 5132563 5132563 5165708 0 5165708 Part IV, Line 2b: ON BEHALF OF OTHER ORTHOPAEDIC ORGANIZATIONS, THE FOUNDATION ACCEPTS CONTRIBUTIONS FOR WHICH IT PERFORMS RECORDKEEPING AND PROVIDES GRANTS REQUESTED BY THOSE ORGANIZATIONS. Part V, Line 4: THE ENDOWMENT FUNDS ARE INVESTED IN A WELL-DIVERSIFIED PORTFOLIO AND DISBURSEMENTS ARE MADE AS OUTLINED IN AN ENDOWMENT SPENDING POLICY TO SUPPORT THE FOUNDATIONS'S MISSION. Part XI, Line 2d - Other Adjustments: CHANGE IN CASH SURRENDER VALUE OF LIFE INSURANCE POLICIES 82,275. CHANGE IN VALUE OF CHARITABLE REMAINDER TURSTS -19,222. Part XII, Line 2d - Other Adjustments: ORTHOPAEDIC PARTNER ENDOWMENT DISTRIBUTION 5,132,563. 1 North America Grants to recipients The DECIPHER Study: DEterminants of Function and Clinically Important Outcomes in Proximal Humerus Fractures in the Elder Population: A National CohoRt 49792 0 0 0 0 0 0 49792 0 49792 North America The DECIPHER Study: DEterminants of Function and Clinically Important Outcomes in Proximal Humerus Fractures in the Elder Population: A National CohoRt 49792 Check 0 0 0 0 0 0 Part I, Line 2: THE RESEARCH GRANTS COMMITTEE IS RESPONSIBLE FOR ALLOCATING RESEARCH FUNDING TO ADVANCE RESEARCH IN THE SPECIALTY OF ORTHOPAEDICS AND IS EMPOWERED TO ESTABLICH CRITIREA FOR THE ALLOCATION AND DISTRIBUTION OF PHILNATHROPIC FUNDS TO ADVACNE RESEARCH IN THE SPECIALTY OF ORTHOPAEDICS, IMPLEMENT AND CONDUCT INDEPENDENT PEER REVIEW PROCESS TO SELECT RESEARCH FUNDING RECIPIENTS, PREPARE AND DISTRIBUTE THE NECESSARY PROMOTIONAL INFORMATION AND APPLICATION FORMS FOR RESEARCH GRANTS AND AWARDS AND TO ACCEPT AND ALLOCATE OR DECLINE TO ALLOCATE, AT ITS SOLE AND ABSOLUTE DISCRETION, GRANTS AND AWARDS FOR RESEARCH. ONE YEAR GRANTS RECIEVE 50% FO THE FUNDS TO STARR, THEN 40% AFTER A SIX-MONTH FINANCIAL REPORT IS RECEIVED. A FINAL SCIENTIFIC AND LAY REPORT IS REQUIRED WITHIN 60 DAYS AFTER THE GRANT ENDS, AND A FINAL FINANCIAL REPORT. ONCE OREF HAS ALL REPORTS THE FINAL 10% OF THE FUNDS ARE RELEASED. ONE-TIME AWARD/EDUCATIONAL GRANT/LECTURESHIP GRANTS RECEIVE FULL PAYMENT AFTER THEY ARE APPROVED. DOCUMENTATION IS IN THE FILE FOR LECTURESHIPS, EDUCATIONAL PROGRAMS AND AWARDS. TWO OR THREE YEAR GRANTS ARE PAID AND SPREAD OVER THE TERM OF THE GRANT. THE 10% WITHHELD IS THE SAME UTNIL ALL REPORTS ARE RECEIVED. THESE MULTI-YEAR GRANTS SUBMIT ANNUAL SCIENTIFIC PROGRESS REPORTS WHICH ARE THEN REVIEWED BY THE ORIGINAL PEER REVIEW COMMITTEE MEMBER. 1 University of Pennsylvania - Office of Research Services 3451 Walnut St Rm P-221 Philadelphia PA 19104 231352685 501(c) (3) 225000 Modulation of Vascularity to Enhance Geriatric Fracture Healing Dartmouth-Hitchcock Medical Center 1 Medical Center Drive Lebanon NH 03756 020222111 501(c) (3) 147724 Validation of Appropriateness Criteria for the Surgical Treatment of Lumbar Degenerative Sponsylolisthesis (LDS) Louisiana State University Health Science Center 1501 Kings Highway Shreveport LA 71103 700702002 501(c) (3) 98000 Mesenchymal Stem Cell Sheet-Mediated Allograft Repair Thomas Jefferson University - Office of Research Administration 125 S 9th Street Sheridan Building 2nd Floor Philadelphia PA 19107 231352651 501(c) (3) 50000 Understanding the Presence of Bacteria in the Glenohumeral Joint by Polymerase Chain Reaction (PCR)-Based Electron Spray Ionization Time-of-Flight Mass Spectrometrry (ESI-TOF-MS): An Evaluation of Non-Arthritic, Arthritic, and Revision Arthroplasty University of Pittsburgh Office of Research University Club 123 University Place Pittsburgh PA 15312 501(c) (3) 20000 Exploring Sarcoma Metastatic Potential University of Utah 75 S 2000 E Room 111 Salt Lake City UT 84112 876000525 501(c) (3) 50000 Evaluating Hindfoot Biomechanics to Improve Function Following Tibiotalar Arthrodesis Thomas Jefferson University - Office of Research Administration 125 S 9th Street Sheridan Building 2nd Floor Philadelphia PA 19107 231352651 501(c) (3) 50000 Arthrofibrosis Modulation by Targeting Collagen Cross-Links University of Pittsburgh Office of Research University Club 123 University Place Pittsburgh PA 15312 250965591 501(c) (3) 50000 Biofilm Dynamics in Periprosthethic Joint Infection NYU Hospital for Joint Diseases 301 East 17th Street New York NY 10003 135562308 501(c) (3) 20000 The Effect of Progranulin on Impaired Fracture Healing in Diabetes The Hospital for Special Surgery 535 East 70th Street New York NY 10021 131624135 501(c) (3) 20000 Targeting Skeletal Metastases Using a Novel HPMA Copolymer Nanomedicine Delivery System Washington University in StLouis Campus Box 1054 - One Brookings Drive St Louis MO 63130 430653611 501(c) (3) 19663 Anatomic Syndesmotic Reduction Utilizing Pre-operative Computed Tomography: A Cadaveric Study Dartmouth-Hitchcock Medical Center 1 Medical Center Drive Lebanon NH 03756 020222111 501(c) (3) 20000 Measuring Near-Infrared Fluorescence Penetration of Normal Connective Tissues to Facilitate Intra-Operative Navigation of Tumor Excision Thomas Jefferson University - Office of Research Administration 125 S 9th Street Sheridan Building 2nd Floor Philadelphia PA 19107 231352651 501(c) (3) 19520 The Effect of Cytokine Levels on the Clinical Outcomes in Patients Undergoing Anterior Cervical Discectomy and Fusion Loyola University Medical Center - Stritch School of Medicine 2160 South First Avenue Maywood IL 60153 361408475 501(c) (3) 19341 Effect of Proton Pump Inhibitors on Bone Formation in a Rat Spinal Arthrodesis Model The University of Iowa - Office of the Vice President for Research - Divisi 2 Gilmore Hall Iowa City IA 52242 426004813 501(c) (3) 4950 Functional Acetabular Orientation and its Relation to Lumbosacral Fusion University of California San Diego 9500 Gilman Drive LaJolla CA 92093 943067788 501(c) (3) 5000 Ewing Sarcoma - A New Treatment with a Dual PI3K/BET Bromodomain Inhibitor University of Pittsburgh Office of Research University Club 123 University Place Pittsburgh PA 15312 250965591 501(c) (3) 5000 Exploring the Interactions Between Osteosarcoma Cells and Lung Cells University of Michigan 4414 Kresge III - 200 Zina Pitcher Place Ann Arbor MI 48109 386006309 501(c) (3) 5000 Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Prophylactic Tamsulosin for Postoperative Urinary Retention in Primary Total Hip and Knee Arthroplasty Patients University of Massachusetts Medical School - Office of Research 55 Lake Avenue North Worcester MA 01655 043167352 501(c) (3) 5000 Predicting Early Failure in Total Knee Arthroplasty University of California San Diego 9500 Gilman Drive LaJolla CA 92093 943067788 501(c) (3) 5000 Biomarkers of Neutrophil Extracellular Trap Formation and their Relationship to Adiposity in Total Joint Arthroplasty Patients Columbia University Medical Center - Sponsored Projects Administration Colu 630 West 168th Street Box 49 New York NY 10032 135598093 501(c) (3) 5000 Adductor Canal Block versus Periarticular Bupivacaine Injection in Total Knee Arthroplasty Cleveland Clinic Foundation 9500 Euclid Avenue Cleveland OH 44195 340714585 501(c) (3) 5000 The Long-Term Effects of Glenoid Component Version in Total Shoulder Arthroplasty University of California San Francisco - Contracts and Grants 3333 California Street Suite 315 San Francisco CA 94143 946036493 501(c) (3) 5000 Biomechanical Evaluation of Augmentation Strategies for Fixation of Proximal Humerus Fractures in Osteoporotic Bone Northwestern University - Office of Sponsored Research 710 North Lake Shore Drive 5th Floo Floo Chicago IL 60611 136216781 501(c) (3) 4999 Development of 3D-Printed Hyperelastic Bone Composites for Bone Regeneration and Spine Fusion Loyola University Chicago 1032 West Sheridan Road Chicago IL 60660 361408475 501(c) (3) 5000 Development of a Real Time Model of Foot and Ankle Kinematics During Simulated Gait: A Pilot Study University of California San Francisco - Contracts and Grants 3333 California Street Suite 315 San Francisco CA 94143 946036493 501(c) (3) 5000 Effect of Ibuprofen on Postoperative Narcotic Consumption and Shoulder Functional Outcomes After Arthroscopic Rotator Cuff Repair Beth Israel Deaconess Medical Center 330 Brookline Ave E/BR 264 Boston MA 02215 042103881 501(c) (3) 5000 Biomechanical Properties of Intramedullary Suture Anchor versus Traditional Tension Band Wiring in Osteoporotic Olecranon Fractures University of California - Los Angeles - Fielding School of Public Health 640 Charles E Young Drive Los Angeles CA 90095 956006143 501(c) (3) 5000 The Effect of Proximal Tibia Anterior Closing Wedge Osteotomy on Anterior Cruciate Ligament Forces and Knee Kinematics: A Biomechanical Study The Hospital for Special Surgery 535 East 70th Street New York NY 10021 131624135 501(c) (3) 5000 Modulating Metastatic Tumor Expansion in Bone Through the Inhibition of the SHN3 Pathway University of Connecticut 438 Whitney Road Ext Unit 1133 Storrs CT 06269 060772160 501(c) (3) 5000 Topical (Intra-Articular) Tranexamic Acid and Transfusion Rates Following Hip Hemiarthroplasty Eastern Orthopaedic Association 110 West Road Suite 227 Towson MD 21204 231738956 501(c) (3) 3000 2016 Regional New Investigator Award Southern Orthopaedic Association 110 West Road Suite 227 Towson MD 21204 630876120 501(c) (3) 3000 2016 Regional New Investigator Award Western Orthopaedic Association 2300 South Flower Street 200 Los Angeles CA 90007 941379470 501(c) (3) 3000 2016 Regional New Investigator Award Orthopaedic Research Society 9400 West Higgins Road Suite 225 Rosemont IL 60018 363180285 501(c) (3) 15000 2016 New Investigator Workshop - Grant Writing Workshop Orthopaedic Research Society 9400 West Higgins Road Suite 225 Rosemont IL 60018 363180285 501(c) (3) 3000 2016 ORS/OREF Orthopaedic Basic Science Course American Academy of Orthopaedic Surgeons 9400 West Higgins Road Rosemont IL 60018 362110592 501(c) (3) 5000 2016 AAOS/OREF/ORS Clinician Scholar Development Program The Hospital for Special Surgery 535 East 70th Street New York NY 10021 131624135 501(c) (3) 50000 Demonstrating the Involvement of the Hedgehog Signaling Pathway in Tendon-to-Bone Healing Using a Novel Transgenic Mouse Rotator Cuff Repair Model University of Maryland Baltimore 620 West Lexington Street - 4th Floo Baltimore MD 21201 526002033 501(c) (3) 50000 Mechanism of Rotator Cuff Fatty Infiltration: Role of Suprascapular Nerve and Aging University of Washington Medical Center 1959 NE Pacific St Seattle WA 98195 916001537 501(c) (3) 50000 Propionibacterium Skin Load and Subtype Distribution on Risk of Positive Deep Cultures in Shoulder Arthroplasty Thomas Jefferson University - Office of Research Administration 125 S 9th Street Sheridan Building 2nd Floo Philadelphia PA 19107 231352651 501(c) (3) 50000 Matrix-Specific Anchors: A Novel Concept for Targeted and Retention of Therapeutic Cells in Musculoskeletal Tissues Vanderbilt University Medical Center - Office of Sponsored Programs 3319 West End Ave Nashville TN 37203 162047682 501(c) (3) 5000 Posterolateral Fusion Augmented by Autogenous Hypertrophic Chondrocytes - A Possible Bone Graft Substitute in Spine Fusion Loyola University Chicago 1032 West Sheridan Road Chicago IL 60660 361408475 501(c) (3) 97898 Transcutaneous Oxygen as a Predictor of Wound Healing Complications in Preoperatively Radiated Soft Tissue Sarcoma The Hospital for Special Surgery 535 East 70th Street New York NY 10021 131624135 501(c) (3) 138500 Non-surgical treatment in young pitchers to improve shoulder kinematics 43 0 Research grant 1 20000 0 Part I, Line 2: THE RESEARCH GRANTS COMMITTEE IS RESPONSIBLE FOR ALLOCATING RESEARCH FUNDING TO ADVANCE RESEARCH IN THE SPECIALTY OF ORTHOPAEDICS AND IS EMPOWERED TO ESTABLICH CRITIREA FOR THE ALLOCATION AND DISTRIBUTION OF PHILNATHROPIC FUNDS TO ADVACNE RESEARCH IN THE SPECIALTY OF ORTHOPAEDICS, IMPLEMENT AND CONDUCT INDEPENDENT PEER REVIEW PROCESS TO SELECT RESEARCH FUNDING RECIPIENTS, PREPARE AND DISTRIBUTE THE NECESSARY PROMOTIONAL INFORMATION AND APPLICATION FORMS FOR RESEARCH GRANTS AND AWARDS AND TO ACCEPT AND ALLOCATE OR DECLINE TO ALLOCATE, AT ITS SOLE AND ABSOLUTE DISCRETION, GRANTS AND AWARDS FOR RESEARCH. ONE YEAR GRANTS RECIEVE 50% FO THE FUNDS TO STARR, THEN 40% AFTER A SIX-MONTH FINANCIAL REPORT IS RECEIVED. A FINAL SCIENTIFIC AND LAY REPORT IS REQUIRED WITHIN 60 DAYS AFTER THE GRANT ENDS, AND A FINAL FINANCIAL REPORT. ONCE OREF HAS ALL REPORTS THE FINAL 10% OF THE FUNDS ARE RELEASED. ONE-TIME AWARD/EDUCATIONAL GRANT/LECTURESHIP GRANTS RECEIVE FULL PAYMENT AFTER THEY ARE APPROVED. DOCUMENTATION IS IN THE FILE FOR LECTURESHIPS, EDUCATIONAL PROGRAMS AND AWARDS. TWO OR THREE YEAR GRANTS ARE PAID AND SPREAD OVER THE TERM OF THE GRANT. THE 10% WITHHELD IS THE SAME UTNIL ALL REPORTS ARE RECEIVED. THESE MULTI-YEAR GRANTS SUBMIT ANNUAL SCIENTIFIC PROGRESS REPORTS WHICH ARE THEN REVIEWED BY THE ORIGINAL PEER REVIEW COMMITTEE MEMBER. X X X 0 0 0 0 0 0 0 1 0 CAROL WARGO VP STRATEGIC PTRS 136688 0 2250 0 2996 0 10504 0 6205 0 158643 0 0 0 SHARON MELLOR PHD CAE FORMER CHIEF EXEC 206267 0 32000 0 2886 0 15236 0 21084 0 277473 0 0 0 Part I, Line 7 BONUSES FOR THE CEO WERE ESTABLISHED BY THE EXECUTIVE COMMITTEE BASED ON PREVIOUS HISTORY FOR BONUSES FOR THIS POSITION AND COMPARED TO INDUSTRY STANDARDS. BONUSES FOR VICE PRESIDENTS AND OTHER KEY EMPLOYEES WERE BASED ON PREVIOUS HISTORY OF BONUSES FOR THESE POSITIONS, SIZE OF THE BONUS POOL AND WORK EFFORT EXPENDED AND RESULTS ACHIEVED. X 15 96921 FAIR MARKET VALUE 0 1 0 Form 990, Part VI, Section B, line 11b THE ORGANIZATION'S CEO, CONTROLLER AND FINANCE COMMITTEE REVIEW THE FORM 990. THE FORM 990 IS PROVIDED TO THE TRUSTEES WHO HAVE OPPORTUNITY TO REVIEW IT PRIOR TO FILING WITH THE IRS. Form 990, Part VI, Section B, line 12c ALL BOARD MEMEBERS ANNUAL SUBMISSION OF DISCLOSURE STATEMENTS ARE ON FILE WITH THE OREF CEO. THE CEO REVIEWS MEETING AGENDAS PRIOR TO THE MEETING AND NOTIFIES LEADERSHIP OF ANY ISSUES THAT NEED TO BE ADDRESSED BEFORE THE DISCUSSIONS TAKE PLACE. ANY INDIVIDUAL WHO GIVE NOTICE OF POTENTIAL CONFLICT IS TO ABSTAIN FROM PARTICIPATING IN ANY ITEM OF BUSINESS WHICH COMES BEFORE THE BOARD. Form 990, Part VI, Section B, line 15 THE FOUNDATION HAS A FORMAL PROCESS TO DETERMINE THE COMPENSATION OF ITS CEO. THE CEO HAS ULTIMATE RESPONSIBILITY FOR IMPLEMENTING THE DECISIONS OF THE BOARD OF TRUSTEES AND FOR SUPERVISING THE FOUNDATION'S MANAGEMEN, ADMINISTRATION AND OPERATIONS. THE PROCESS INCLUDES THE FOLLOWING ELEMENTS: 1) REVEIW AND APPROVAL BY THE BOARD OF TRUSTEESOR COMPENSATION COMMITTEE; 2) USE OF COMPARABLE COMPENSATION DATA; AND 3) CONTEMPORANEOUS DOCUMENTATION AND RECORD KEEPING. Form 990, Part VI, Section C, line 19 THE ORGANIZATION MADE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST FOR THE SAME PERIOD OF DISCLOSURE AS SET FORTH IN IRC SECTION 6104(d). CHARITABLE REMAINDER TRUSTS CHARITABLE TRUST IL ORTHOPAEDIC RESEARCH AND EDUCATION FOUNDATION T 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0